1800 244 735

Helpline (02) 9874 9777

Coming soon: HD Therapeutics Conference 2012

An oasis of hope in the desert: the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California, begins on 27th February. We’ll be bringing you live updates via Twitter and the web.

An exciting time

If 2011 is anything to go by, we predict that 2012 will be a big year for Huntington’s disease treatment research.

The new year has already brought exciting news of gene silencing success in primate trials and striking improvement in HD mice from injection of the ‘brain fat’ GM1.

Annual Therapeutics Conference

For the last 7 years the annual HD Therapeutics Conference in Palm Springs, California, has been a significant occasion for HD drug-hunters. It’s where the most exciting and cutting-edge treatment research is announced and discussed. It’s also a gathering of the world’s top HD researchers where ideas are shared and fruitful collaborations formed and nurtured.

The Conference begins very soon – Monday 27th February, to be exact. Your intrepid HDBuzz reporters Ed Wild and Jeff Carroll are going undercover at the Conference to bring you the latest news and buzz from the meeting.

The inside scoop from HDBuzz

Each day, we’ll be tweeting live updates from 9am to 6pm Pacific Time (that’s roughly 5pm to 2am in Europe). Follow @HDBuzzFeed on Twitter now, so you don’t miss anything.

If you prefer a daily digest, check HDBuzz.net or any of the HD sites that carry HDBuzz syndicated content. Each day’s news will be gathered together into a new article each evening, with our ever-popular ‘sunset conclusions’ to put things in context.

In the coming weeks, we’ll also bring you featured stories and interviews with some top scientists from the Conference.

Get in touch!

We want to hear from you, too, so send your questions, comments and queries to [email protected] or tweet @HDBuzzFeed now or throughout the Conference.

So, get following, sign up for email updates and check the web frequently. Here’s looking forward to an inspiring Therapeutics Conference.

Latest Research Articles

Update on the PTC Therapeutics PIVOT-HD Trial

Published date: 2 November, 2022

Recruitment of participants into the US arm of the PTC Therapeutics PIVOT-HD trial has been paused. Since this announcement, there have been a lot of different (and confusing!) headlines about the pause in recruitment. In this article, we will lay out what is going on and what this announcement means. What is the aim of ... Read more

Forward momentum for Roche and Wave in latest news about huntingtin-lowering trials

Published date: 30 September, 2022

In the past week or so, during and following a big HD research conference, two companies developing medicines for Huntington’s disease announced news about their huntingtin-lowering drugs. First, the pharmaceutical company Roche announced plans for a new clinical trial of tominersen. Then, the genetic medicines company Wave Life Sciences shared early data showing that its ... Read more

Focusing in on fibrils; scientists give us a glimpse of huntingtin protein clumps

Published date: 8 September, 2022

A group of scientists from the EPFL in Lausanne, Switzerland have published a paper in the Journal of the American Chemical Society, describing clumps made up of a fragment of the huntingtin protein. A word that’s commonly used to describe these is “aggregates.” Using very powerful microscopes, the team was able to zoom in and ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 4

Published date: 2 September, 2022

DNA repair and CAG repeat instability The effect of HTT lowering on CAG repeat expansions Welcome to last day of the @hdfcures conference! We’ll only be sharing a few talks from today’s sessions, which focus on DNA repair. The first is from HDBuzz’s very own Jeff Carroll! Jeff will be sharing his work on HTT ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 3

Published date: 1 September, 2022

Pre-clinical work moving toward trials New tools to lower HTT showing promise in animal models Welcome back! The first talk we will be tweeting about today is from Anastasia Khvorova, who will be telling us about her teams work on lowering of Huntingtin using technology called RNAi. One of the problems in studying drug delivery ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 2

Published date: 31 August, 2022

We’re back for day 2 at @hdfcures! This morning’s talks will be focused on clinical trial planning and therapeutic updates from clinical studies. The sheer number of talks related to human trials compared to previous years is so encouraging! Updating metrics for clinical trials A better system for disease categorization The first talk of this ... Read more